Hot Features
プレミアム
Glaukos Corporation (GKOS)
NYSE
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. David Frank HoffmeisterIndependent Director | 15.00k | 370.35k | Derivative Exercise and Retained Stock | 24.69 | 82.99k | 22.06% |
| 2026-05-14 | Dr. Gilbert H. KlimanIndependent Director | -5.00k | 580.35k | Derivative Exercise and Sale | 24.69 - 140.76 | 32.80k | - |
| 2026-05-11 | Dr. Gilbert H. KlimanIndependent Director | -5.00k | 551.55k | Derivative Exercise and Sale | 24.69 - 135.00 | 32.80k | - |
| 2026-04-30 | Mr. Alex R. ThurmanSenior VP & CFO | -10.00k | 1.01M | Derivative Exercise and Sale | 38.68 - 140.00 | 38.45k | - |
| 2026-05-01 | Mr. Joseph E. GilliamPresident & COO | -19.57k | 2.81M | 売り | 143.54 | 29.49k | -39.89% |
| 2026-05-01 | Dr. Leana S. WenIndependent Director | -1.70k | 243.70k | 売り | 143.35 | 17.01k | -9.09% |
| 2026-04-10 | Dr. Tomas NavratilChief Development Officer | -2.09k | 246.18k | Automatic Disposition | 116.72 - 120.23 | 50.58k | -3.97% |
| 2026-04-02 | Dr. Tomas NavratilChief Development Officer | -2.98k | 326.28k | Sale to Issuer | 109.60 | 52.67k | -5.35% |
| 2026-04-02 | Mr. Alex R. ThurmanSenior VP & CFO | -1.59k | 174.15k | Sale to Issuer | 109.60 | 38.45k | -3.97% |
| 2026-04-02 | Mr. Joseph E. GilliamPresident & COO | -3.17k | 347.32k | Sale to Issuer | 109.60 | 49.07k | -6.07% |
| 2026-04-02 | Mr. Thomas William BurnsChairman & CEO | -9.94k | 1.09M | Sale to Issuer | 109.60 | 567.04k | -1.72% |
| 2026-04-01 | Mr. Thomas William BurnsChairman & CEO | -180.31k | 0.00 | Other Disposition | - | 567.04k | -24.13% |
| 2026-03-31 | Dr. Tomas NavratilChief Development Officer | -5.80k | 635.46k | Sale to Issuer | 109.60 | 49.65k | -10.46% |
| 2026-03-25 | Mr. Alex R. ThurmanSenior VP & CFO | -2.51k | 267.32k | Automatic Disposition | 106.46 | 36.74k | -6.40% |
| 2026-03-24 | Mr. Thomas William BurnsChairman & CEO | -2.74k | 288.75k | Sale to Issuer | 105.23 | 1.70M | -0.16% |
| 2026-03-23 | Dr. Tomas NavratilChief Development Officer | -5.17k | 548.69k | Sale to Issuer | 105.23 - 106.84 | 43.75k | -10.58% |
| 2026-03-24 | Mr. Alex R. ThurmanSenior VP & CFO | -1.52k | 160.07k | Automatic Disposition | 105.24 | 39.25k | -3.73% |
| 2026-03-23 | Mr. Alex R. ThurmanSenior VP & CFO | -3.25k | 343.98k | Sale to Issuer | 105.23 - 106.84 | 39.25k | -7.65% |
| 2026-03-23 | Mr. Joseph E. GilliamPresident & COO | -15.12k | 1.60M | Sale to Issuer | 105.23 - 106.84 | 46.41k | -24.57% |
| 2026-03-17 | Mr. Alex R. ThurmanSenior VP & CFO | -625.00 | 61.97k | Automatic Disposition | 99.15 | 36.74k | -1.67% |
| 2026-03-16 | Mr. Alex R. ThurmanSenior VP & CFO | -614.00 | 60.75k | Sale to Issuer | 98.94 | 36.74k | -1.64% |
| 2026-03-16 | Mr. Joseph E. GilliamPresident & COO | -1.19k | 117.64k | Sale to Issuer | 98.94 | 33.67k | -3.41% |
| 2026-03-16 | Mr. Thomas William BurnsChairman & CEO | -2.80k | 277.13k | Sale to Issuer | 98.94 | 1.70M | -0.16% |
| 2026-03-16 | Dr. Tomas NavratilChief Development Officer | -1.03k | 101.08k | Automatic Disposition | 97.33 - 99.05 | 37.94k | -2.65% |
| 2026-03-16 | Dr. Tomas NavratilChief Development Officer | -958.00 | 94.78k | Sale to Issuer | 98.94 | 37.94k | -2.46% |
| 2026-03-13 | Mr. Joseph E. GilliamPresident & COO | -2.46k | 238.86k | Sale to Issuer | 97.02 | 32.72k | -7.00% |
| 2026-03-13 | Dr. Tomas NavratilChief Development Officer | -1.07k | 104.20k | Sale to Issuer | 97.02 | 37.16k | -2.81% |
| 2026-03-13 | Mr. Thomas William BurnsChairman & CEO | -5.21k | 505.67k | Sale to Issuer | 97.02 | 1.69M | -0.31% |
| 2026-03-05 | Dr. Tomas NavratilChief Development Officer | -361.00 | 40.47k | Sale to Issuer | 112.10 | 35.13k | -1.02% |
| 2026-03-05 | Mr. Thomas William BurnsChairman & CEO | -1.10k | 123.09k | Sale to Issuer | 112.10 | 1.69M | -0.06% |
| 2026-02-24 | Mr. Thomas William BurnsChairman & CEO | -4.06k | 483.71k | Sale to Issuer | 119.17 | 1.69M | -0.24% |
| 2026-02-24 | Dr. Tomas NavratilChief Development Officer | -396.00 | 47.19k | Sale to Issuer | 119.17 | 34.47k | -1.14% |
| 2026-02-24 | Mr. Joseph E. GilliamPresident & COO | -1.06k | 125.96k | Sale to Issuer | 119.17 | 30.65k | -3.33% |
| 2026-02-19 | Ms. Aimee S. WeisnerIndependent Director | -15.00k | 1.39M | Derivative Exercise and Sale | 24.69 - 118.56 | 47.58k | - |
| 2026-02-19 | Ms. Aimee S. WeisnerIndependent Director | -980.00 | 0.00 | Other Disposition | - | 47.58k | -2.02% |
| 2026-02-09 | Mr. Thomas William BurnsChairman & CEO | 166.00k | 5.13M | Derivative Exercise and Retained Stock | 30.92 | 1.69M | 10.93% |
| 2026-02-06 | Mr. Thomas William BurnsChairman & CEO | -67.35k | 0.00 | Other Disposition | - | 1.69M | -3.84% |
| 2026-01-22 | Mr. Marc A. StapleyIndependent Director | -15.00k | 1.55M | Derivative Exercise and Sale | 24.69 - 129.78 | 34.61k | - |
| 2026-01-22 | Mr. Joseph E. GilliamPresident & COO | -10.50k | 761.10k | Derivative Exercise and Sale | 55.18 - 129.28 | 29.76k | - |
| 2026-01-21 | Mr. Joseph E. GilliamPresident & COO | -4.50k | 312.75k | Derivative Exercise and Sale | 55.18 - 124.65 | 29.76k | - |
| 2026-01-08 | Mr. Thomas William BurnsChairman & CEO | -275.00k | 27.09M | Derivative Exercise and Sale | 16.49 - 115.00 | 1.52M | - |
| 2025-12-30 | Mr. Thomas William BurnsChairman & CEO | -1.10k | 125.44k | Sale to Issuer | 114.24 | 1.52M | -0.07% |
| 2025-12-30 | Dr. Tomas NavratilChief Development Officer | -510.00 | 58.26k | Sale to Issuer | 114.24 | 33.89k | -1.48% |
| 2025-12-09 | Dr. Gilbert H. KlimanIndependent Director | -5.00k | 412.90k | Derivative Exercise and Sale | 24.69 - 107.27 | 32.34k | - |
| 2025-11-25 | Mr. Alex R. ThurmanSenior VP & CFO | -315.00 | 33.08k | Automatic Disposition | 105.00 | 36.74k | -0.85% |
| 2025-11-18 | Mr. Joseph E. GilliamPresident & COO | -19.34k | 1.74M | 売り | 90.00 | 29.76k | -39.39% |
| 2025-09-23 | Mr. Joseph E. GilliamPresident & COO | -1.06k | 89.43k | Sale to Issuer | 84.69 | 49.10k | -2.11% |
| 2025-09-23 | Mr. Thomas William BurnsChairman & CEO | -4.06k | 343.76k | Sale to Issuer | 84.69 | 1.52M | -0.27% |
| 2025-09-22 | Dr. Tomas NavratilChief Development Officer | -517.00 | 43.54k | Automatic Disposition | 82.79 - 84.70 | 33.37k | -1.53% |
| 2025-09-23 | Dr. Tomas NavratilChief Development Officer | -483.00 | 40.91k | Sale to Issuer | 84.69 | 33.37k | -1.43% |
| 2025-09-19 | Dr. Tomas NavratilChief Development Officer | -510.00 | 42.57k | Sale to Issuer | 83.47 | 33.40k | -1.50% |
| 2025-09-19 | Mr. Thomas William BurnsChairman & CEO | -1.10k | 91.65k | Sale to Issuer | 83.47 | 1.51M | -0.07% |
| 2025-09-11 | Dr. Tomas NavratilChief Development Officer | -5.14k | 453.62k | Automatic Disposition | 87.98 - 88.61 | 32.88k | -13.52% |
| 2025-06-11 | Mr. David Frank HoffmeisterIndependent Director | 25.00k | 800.00k | Derivative Exercise and Retained Stock | 32.00 | 67.43k | 58.92% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
